Silymarin Ascending Multiple Oral Dosing Phase I Study in Noncirrhotic Patients With Chronic Hepatitis C

Silymarin, derived from the milk thistle plant Silybum marianum, is widely used for self-treatment of liver diseases, including hepatitis C virus (HCV), and its antiviral activity has been demonstrated in vitro and in HCV patients administered an intravenous formulation of the major silymarin flavon...

詳細記述

保存先:
書誌詳細
主要な著者: Hawke, Roy L., Schrieber, Sarah J., Soule, Tedi A., Wen, Zhiming, Smith, Philip C., Reddy, K. Rajender, Wahed, Abdus S., Belle, Steven H., Afdhal, Nezam H., Navarro, Victor J., Berman, Josh, Liu, Qi-Ying, Doo, Edward, Fried, Michael W.
フォーマット: Artigo
言語:Inglês
出版事項: 2009
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3086763/
https://ncbi.nlm.nih.gov/pubmed/19841158
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0091270009347475
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料